{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:54:18Z","timestamp":1787162058320,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejps.2022.106239","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:34:25Z","timestamp":1655260465000},"page":"106239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide"],"prefix":"10.1016","volume":"176","author":[{"given":"Naoya","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Fuchigami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaharu","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjian","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Tsurumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayori","family":"Hagimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106239_bib0001","first-page":"889","article-title":"Use of the post-insertion method for the formation of ligand-coupled liposomes","volume":"7","author":"Allen","year":"2002","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejps.2022.106239_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.02.040","article-title":"Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: challenges and opportunities","volume":"277","author":"Belfiore","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2022.106239_bib0003","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1242\/jcs.095810","article-title":"Integrin trafficking at a glance","volume":"125","author":"Bridgewater","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejps.2022.106239_bib0004","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jsps.2020.09.003","article-title":"Optimization of post-insertion method to conjugate Doxil with anti-CD133 monoclonal antibodies: investigating the specific binding and cytotoxicity to colorectal cancer cells in vitro","volume":"28","author":"Dadashi Noshahr","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejps.2022.106239_bib0005","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1016\/S0040-4039(00)01060-1","article-title":"An improved synthesis of a selective \u03b1v\u03b23-integrin antagonist cyclo(-RGDfK-)","volume":"41","author":"Dai","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejps.2022.106239_bib0006","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.addr.2017.05.006","article-title":"Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment","volume":"119","author":"David","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2022.106239_bib0007","article-title":"Synthesis and evaluation of high functionality and quality cell-penetrating peptide conjugated lipid for octaarginine modified pegylated liposomes in U251 and U87 glioma cells","author":"El-Gamal","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106239_bib0008","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.bmcl.2016.01.079","article-title":"Synthesis of linear and cyclic peptide\u2013PEG\u2013lipids for stabilization and targeting of cationic liposome\u2013DNA complexes","volume":"26","author":"Ewert","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejps.2022.106239_bib0009","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.2174\/13816128113199990375","article-title":"The smart targeting of nanoparticles","volume":"19","author":"Friedman","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2022.106239_bib0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2017.11.042","article-title":"Folate-targeted liposomal nitrooxy-doxorubicin: an effective tool against P- glycoprotein-positive and folate receptor-positive tumors","volume":"270","author":"Gazzano","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2022.106239_bib0011","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.biomaterials.2014.04.031","article-title":"Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin \u03b1v\u03b23 clustering","volume":"35","author":"Guo","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2022.106239_bib0012","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejps.2018.07.036","article-title":"Synthesis of high functionality and quality mannose-grafted lipids to produce macrophage-targeted liposomes","volume":"123","author":"Hagimori","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106239_bib0013","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases","author":"Haran","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2022.106239_bib0014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0005-2736(01)00357-1","article-title":"In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach","volume":"1513","author":"Iden","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2022.106239_bib0015","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1016\/S0006-3495(03)74798-5","article-title":"Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids","volume":"85","author":"Johnsson","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejps.2022.106239_bib0016","doi-asserted-by":"crossref","first-page":"39805","DOI":"10.1038\/srep39805","article-title":"A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins","volume":"7","author":"Kapp","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106239_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/bip.20596","article-title":"Mutational analysis of protein solubility enhancement using short peptide tags","volume":"85","author":"Kato","year":"2007","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejps.2022.106239_bib0018","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2011.03.012","article-title":"Dual-ligand modification of pegylated liposomes shows better cell selectivity and efficient gene delivery","volume":"153","author":"Kibria","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2022.106239_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2012.02.009","article-title":"Analysis of cause of failure of new targeting peptide in pegylated liposome: molecular modeling as rational design tool for nanomedicine","volume":"46","author":"Lehtinen","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106239_bib0020","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/j.ccr.2011.06.028","article-title":"The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) \u201cclick\u201d reaction and its applications. An overview","volume":"255","author":"Liang","year":"2011","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejps.2022.106239_bib0021","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1208\/s12249-015-0462-2","article-title":"A novel folate-targeted nanoliposomal system of doxorubicin for cancer targeting","volume":"17","author":"Lohade","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2022.106239_bib0022","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jmbi.2001.5214","article-title":"Transmembrane domain mediated self-assembly of major coat protein subunits from Ff bacteriophage","volume":"315","author":"Melnyk","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejps.2022.106239_bib0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/bp049839z","article-title":"Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis","volume":"21","author":"Nellis","year":"2005","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.ejps.2022.106239_bib0024","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1014434732752","article-title":"Use of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicity","volume":"19","author":"Moreira","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2022.106239_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2022.100450","article-title":"Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics","volume":"44","author":"Mukai","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2022.106239_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tibtech.2013.09.007","article-title":"Ligand-targeted liposome design: challenges and fundamental considerations","volume":"32","author":"Noble","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejps.2022.106239_bib0027","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1021\/ja5079464","article-title":"Synthetic aptamer-polymer hybrid constructs for programmed drug delivery into specific target cells","volume":"136","author":"Oh","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2022.106239_bib0028","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1535-7163.MCT-15-0579","article-title":"Folate receptor\u2013targeted polymeric micellar nanocarriers for delivery of orlistat as a repurposed drug against triple-negative breast cancer","volume":"15","author":"Paulmurugan","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2022.106239_bib0029","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2010.06.019","article-title":"Post-insertion into lipid nanocapsules (LNCs): from experimental aspects to mechanisms","volume":"396","author":"Perrier","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2022.106239_bib0030","doi-asserted-by":"crossref","first-page":"13711","DOI":"10.1021\/jp901727q","article-title":"Wormlike micelle formation in peptide-lipid conjugates driven by secondary structure transformation of the headgroups","volume":"113","author":"Shimada","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejps.2022.106239_bib0031","doi-asserted-by":"crossref","first-page":"9974","DOI":"10.1016\/j.tet.2010.10.033","article-title":"Expeditious preparation of triazole-linked glycolipids via microwave accelerated click chemistry and their electrochemical and biological assessments","volume":"66","author":"Song","year":"2010","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejps.2022.106239_bib0032","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijpharm.2017.02.041","article-title":"Ligand peptide-grafted pegylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: the effect of serine-glycine repeated peptides as a spacer","volume":"521","author":"Suga","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2022.106239_bib0033","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1021\/acs.molpharmaceut.8b00476","article-title":"Development of high-functionality and -quality lipids with RGD peptide ligands: application for pegylated liposomes and analysis of intratumoral distribution in a murine colon cancer model","volume":"15","author":"Suga","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2022.106239_bib0034","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jddst.2018.12.037","article-title":"Synthesis of a high functionality and quality lipid with gp130 binding hydrophobic peptide for the preparation of human glioma cell-targeted pegylated liposomes","volume":"49","author":"Suga","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2022.106239_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2310\/7290.2009.00021","article-title":"Comparative analysis of nanoparticle-antibody conjugations: carbodiimide versus click chemistry","volume":"8","author":"Thorek","year":"2009","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.ejps.2022.106239_bib0036","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-5793(96)00452-8","article-title":"Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time","volume":"386","author":"Uster","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2022.106239_bib0037","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1021\/acs.bioconjchem.5b00359","article-title":"Genetically encoded azide containing amino acid in mammalian cells enables site-specific antibody\u2013drug conjugates using click cycloaddition chemistry","volume":"26","author":"VanBrunt","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2022.106239_bib0038","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1021\/bc800077y","article-title":"In vivo tumor cell targeting with \u201cclick\u201d nanoparticles","volume":"19","author":"von Maltzahn","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejps.2022.106239_bib0039","first-page":"4185","article-title":"Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2022.106239_bib0040","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/jps.20397","article-title":"Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo","volume":"94","author":"Xiong","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2022.106239_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000479","article-title":"Tuning curvature and stability of monoolein bilayers by designer lipid-like peptide surfactants","volume":"2","author":"Yaghmur","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejps.2022.106239_bib0042","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2016.01.002","article-title":"Ligand-targeted theranostic nanomedicines against cancer","volume":"240","author":"Yao","year":"2016","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:02:01Z","timestamp":1760529721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"alternative-id":["S0928098722001245"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106239","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106239"}}